Propentofylline
Top View
- List of Common Prohibited Substance for the California Equine Medication
- Caffeine/Pentoxifylline Elisa Kit Instructions Product #106419 & 106416 Forensic Use Only
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Non-Lipid Benzofuran Ethanolamine Structures
- 99 03 Review of the Use of Propentofylline in the Treatment Of
- CHAPTER 9 Therapeutic Agents
- Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
- Synaptic Therapy in Alzheimer's Disease: a CREB-Centric Approach
- On the Expression of Cell Cycle Blocks and S-Phase Content After Irradiation Damage
- Example List of Forbidden Substances
- A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
- Methylxanthines for Prolonged Non-Specific Cough in Children (Review)
- Wo 2007/044693 A2
- Propentofylline Reduces Glial Scar Development Following Gliotoxic
- Arruda, Maria Augusta and Stoddart, Leigh A. and Gherbi, Karolina and Briddon, Stephen J. and Kellam, Paul and Hill, Stephen J
- Drugs and Medications
- The Activity of Phagocytic Cells After in Vivo Administration of Propentofylline in Mice
- SCHIZOPHRENIA Factsheet September 2020
- Compartmentalized Signaling in Aging and Neurodegeneration